Katja Zirlik

4.2k citations
45 papers · 2.4k indexed · 1 hit paper · h-index 25

Katja Zirlik

44 papers receiving 2.4k citations

Hit Papers

Chronic lymphocytic leukaemia is driven by antigen-indepe...3792012202620162021100200300

Peers

Katja Zirlik
Comparison fields: 5 of 90
  • Genetics 894
  • Pathology and Forensic Medicine 707
  • Hematology 437
  • Immunology 814
  • Oncology 581
Replace Koji Isozaki with:
Koji Isozaki Japan
Yaping Shou United States
Elisa Cerri United States
Ellen Schlette United States
Teresa K. Kimlinger United States
Tammy Price-Troska United States
Antonella Zucchetto Italy
Enrico Tiacci Italy
Paola Omedè Italy
Paulo De Sepulveda France
Katja Zirlik relative to Koji Isozaki Japan Koji Isozaki's profile →
Citations per field
00.5×3.8×
Koji Isozaki · 1×
Citations per year

Countries citing papers authored by Katja Zirlik

Since Specialization
Citations

This map shows the geographic impact of Katja Zirlik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Zirlik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Zirlik more than expected).

Fields of papers citing papers by Katja Zirlik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Zirlik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Zirlik. The network helps show where Katja Zirlik may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Katja Zirlik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Katja Zirlik Line = papers co-authored together Katja Zirlik links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 2018164
3 201837
4 201719
5 201613
6 201612
7 201540
8 201511
9 201461
10 201410
11 201329
12 201231
13 201051
14 201019
15 201056
16 201025
17 2008407
18 2007262
19 200631
20 200617

About Katja Zirlik

Katja Zirlik is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine, having authored 45 papers that have together received 2.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (5 papers), Immune Cell Function and Interaction (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Genetics (894 citations), Pathology and Forensic Medicine (707 citations) and Hematology (437 citations). Katja Zirlik has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Hendrik Veelken, Christine Dierks, Justus Duyster, Hassan Jumaa, Maike Buchner, Markus Warmuth, Meike Burger, Annette Schmitt‐Graeff, Paul W. Manley and Mario Stegert. Their work appears in journals such as Blood, Cancer Research, Leukemia, Annals of Hematology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026